Axsome Therapeutics CEO buys, sells shares in December 2025 transactions.

Axsome Therapeutics, Inc. (AXSM) recently announced that Tabuteau Herriot, Director, 10% Owner, and Chief Executive Officer, engaged in several transactions involving the purchase and sale of shares. On December 2, 2025, Tabuteau Herriot purchased 49,252 shares at a price of $8.02 per share and sold the same number of shares at $144.59 per share. On December 3, 2025, Tabuteau Herriot purchased 20,163 shares at $8.02 per share and sold the same number of shares at $146.94 per share. Finally, on December 4, 2025, Tabuteau Herriot purchased 10,558 shares at $8.02 per share and sold the same number of shares at $148.18 per share. These transactions reflect the ongoing activity of Tabuteau Herriot in the company's shares.